Equine Healthcare Market to Surpass US$ 1.3 Billion by 2035, Growing at a 4.8% CAGR

The equine healthcare market was valued at approximately US$ 0.8 billion in 2024 and is projected to expand at a CAGR of 4.8% from 2025 to 2035. At this growth rate, the market is expected to surpass US$ 1.3 billion by 2035, driven by increasing demand for advanced veterinary care, preventive healthcare products, diagnostic solutions, and therapeutic treatments for horses.

Therapeutics such as corticosteroids are being extensively used as joint injections for horses. Bisphosphonates such as tiludronate disodium (Tildren) and clondronate (Osphos) are labeled for controlling clinical signs associated with navicular syndrome. There is a need for research surrounding bisphosphonate’s use in horses under the age of four.

Review significant findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1603

Market Overview

The global equine healthcare market is expected to grow owing to the rise in equine population due to increasing frequency of horse ownership, sports, and recreational activities. Moreover, growing demand for preventive care including vaccinations, deworming, and regular check-ups is expected to foster the overall market growth in the upcoming future. Furthermore, the equine healthcare industry growth is primarily fueled by the rising population of domesticated and sport horses globally. As equestrian sports continue to gain popularity-ranging from horse racing and dressage to endurance and rodeo-there is growing demand for high-quality veterinary care.

Key Market Growth Drivers

• Expanding Equestrian Sports & Recreation: Growth in horse racing, show jumping, dressage, and recreational riding globally drives spending on preventive care and performance optimization.
• Rising Incidence of Equine Pathogens & Parasites: Outbreaks of equine influenza, Equine Herpesvirus (EHV), and internal parasite resistance necessitate updated vaccination programs and advanced anthelmintics.
• Emergence of Regenerative Medicine: Widespread integration of Platelet-Rich Plasma (PRP), stem cell therapy, and prolotherapy for tendon, joint, and ligament injury repair in performance horses.
• Growth in Companion Animal Humanization: Increasing pet-like attachment to horses fuels willingness to invest in high-end veterinary diagnostics and specialized feed additives.

Analysis of Key Players

The competitive environment involves major global animal health corporations and dedicated veterinary biotech developers:

• Zoetis
• Arthrex, Inc.
• Dechra Pharmaceuticals
• Boehringer Ingelheim Animal Health USA Inc.
• Ceva
• Heska Corporation
• Merck & Co., Inc.,
• Esaote SpA
• IDEXX
• Covetrus
• Elanco
• Cargill, Incorporated
• Santa Cruz Biotechnology Inc.
• Other Prominent Players

Key Player Strategies

• Advancements in Regenerative & Targeted Therapies: Launching point-of-care equine blood processing systems and long-acting injectables for rapid soft-tissue healing.
• Specialized Vaccine & Parasiticide Innovation: Formulating multi-valent vaccines and palatable oral gels with minimal systemic toxicity to battle resistant parasitic strains.
• Collaborative Veterinary Alliances: Teaming up with equine hospitals and university research centers to advance genetic diagnostic screening and individualized treatment protocols.

Access detailed insights by visiting our full report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1603

Market Challenges & Opportunities

Challenges

• High Cost of Specialized Veterinary Interventions: Advanced equine surgeries, stem cell procedures, and MRI/CT diagnostic modalities carry high price tags that restrict adoption among non-commercial horse owners.
• Parasitic Drug Resistance: Rising resistance of gastrointestinal parasites to conventional anthelmintics poses ongoing clinical hurdles for herd management.

Opportunities

• Point-of-Care & Mobile Diagnostic Systems: Development of portable digital radiography, endoscopy, and ultrasonography units tailored for field veterinarians.
• E-Commerce Expansion for Feed Additives & Over-the-Counter Care: Growing adoption of online ordering platforms for specialized supplements, joint care products, and grooming health supplies.

Market Segmentation

• Product Type
• Therapeutics
• Drugs
• Anti-Infective
• Anti-inflammatory
• Parasiticides
• Others (Hormone and Substitutes, etc.)
• Vaccine
• Inactivated
• Live Attenuated
• Recombinant
• Others (DNA vaccine, etc.)
• Supplemental Feed additives
• Proteins and amino acids
• Vitamins
• Enzymes
• Minerals
• Others (Probiotics, etc.)
• Regenerative Medicine
• Diagnostics
• Diagnostic Kits & Reagents
• Instruments
• Indication
• Equine Influenza
• Equine Herpes virus (EHV)
• Equine Encephalomyelitis
• West Nile Virus
• Equine Rabies
• Potomac Horse Fever
• Osteoarthritis
• Tetanus
• Others (Equine Infectious Anemia, etc.)
• End-user
• Veterinary Hospitals
• Equine Clinics
• Equestrian Facilities
• Others

Buy this Premium Research Report to gain valuable industry intelligence - https://www.transparencymarketresearch.com/checkout.php?rep_id=1603<ype=S

Frequently Asked Questions

·        How big was the global Equine Healthcare Market in 2024?

The global equine healthcare market was valued at US$ 0.8 Bn in 2024.

·        How big will the global equine healthcare business be in 2035?

Equine Healthcare business is projected to cross US$ 1.3 Bn by the end of 2035.

·        What are the key factors driving the demand for equine healthcare?

Growing incidence of equine diseases and rising research and development across the veterinary field.

·        What will be the CAGR of the equine healthcare industry during the forecast period?

The CAGR is anticipated to be 4.8% from 2025 to 2035.

·        Which region will account for a major share of the equine healthcare market during the forecast period?

North America is expected to account for the largest share from 2025 to 2035.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com  

Sales Inquiries: sales@transparencymarketresearch.com  

Media Inquiries: media@transparencymarketresearch.com